A Study of BBI608 in Adult Patients With Advanced, Refractory Hematologic Malignancies
Clinical trial NCT02352558 · COMPLETED
Trial details
- NCT number
- NCT02352558
- Sponsor
- Sumitomo Pharma America, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-05-01
- Primary completion
- 2018-12-14
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.